-
1
-
-
0034609196
-
Meerwaarde van positronemissietomografie met als tracer fluor-18-deoxyglucose (FDG-PET) bij klinische probleemgevallen in de oncologie
-
Comans E.F.I., Hoekstra O.S., Hoekman K., van der Hoeven J.J.M., Golding R.P., Teule G.J.J. Meerwaarde van positronemissietomografie met als tracer fluor-18-deoxyglucose (FDG-PET) bij klinische probleemgevallen in de oncologie. Ned. Tijdschr. Geneeskd. 144:2000;1520-1528
-
(2000)
Ned. Tijdschr. Geneeskd.
, vol.144
, pp. 1520-1528
-
-
Comans, E.F.I.1
Hoekstra, O.S.2
Hoekman, K.3
Van Der Hoeven, J.J.M.4
Golding, R.P.5
Teule, G.J.J.6
-
2
-
-
0037140187
-
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: The PLUS multicentre randomised trial
-
Van Tinteren H., Hoekstra O.S., Smit E.F., et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 359:2002;1388-1392
-
(2002)
Lancet
, vol.359
, pp. 1388-1392
-
-
Van Tinteren, H.1
Hoekstra, O.S.2
Smit, E.F.3
-
3
-
-
0034721257
-
Preoperative staging of non-small cell lung cancer with positron emission tomography
-
Pieterman R.M., van Putten J.W.G., Meuzelaar J.J., et al. Preoperative staging of non-small cell lung cancer with positron emission tomography. N. Engl. J. Med. 343:2000;254-261
-
(2000)
N. Engl. J. Med.
, vol.343
, pp. 254-261
-
-
Pieterman, R.M.1
Van Putten, J.W.G.2
Meuzelaar, J.J.3
-
4
-
-
2642678437
-
Diagnosing and staging of pancreatic carcinoma, what is necessary?
-
Bottger T.C., Boddin J., Duber C., Heintz A., Kuchle R., Junginger T. Diagnosing and staging of pancreatic carcinoma, what is necessary? Oncology. 55(2):1998;122-129
-
(1998)
Oncology
, vol.55
, Issue.2
, pp. 122-129
-
-
Bottger, T.C.1
Boddin, J.2
Duber, C.3
Heintz, A.4
Kuchle, R.5
Junginger, T.6
-
5
-
-
0030910466
-
Diagnostic workup of patients with suspected pancreatic carcinoma
-
Gloor B., Todd K.E., Reber H.A. Diagnostic workup of patients with suspected pancreatic carcinoma. Cancer. 79(9):1997;1780-1786
-
(1997)
Cancer
, vol.79
, Issue.9
, pp. 1780-1786
-
-
Gloor, B.1
Todd, K.E.2
Reber, H.A.3
-
7
-
-
8544283014
-
Fluorine-18 fluordeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: A report of 106 cases
-
Zimny M., Bares R., Faß J., Adam G., Cremerius U., Dohmen B., et al. Fluorine-18 fluordeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur. J. Nucl. Med. 24:1997;678-682
-
(1997)
Eur. J. Nucl. Med.
, vol.24
, pp. 678-682
-
-
Zimny, M.1
Bares, R.2
Faß, J.3
Adam, G.4
Cremerius, U.5
Dohmen, B.6
-
8
-
-
0031775024
-
Diagnosis of pancreatic carcinoma: Role of FDG PET
-
Keogan M.T., Tyler D., Clark L., Branch M.S., Mc Dermott V.G., De Long D.M., et al. Diagnosis of pancreatic carcinoma: role of FDG PET. AJR. 171:1998;1565-1570
-
(1998)
AJR
, vol.171
, pp. 1565-1570
-
-
Keogan, M.T.1
Tyler, D.2
Clark, L.3
Branch, M.S.4
Mc Dermott, V.G.5
De Long, D.M.6
-
9
-
-
0032744477
-
Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma
-
Delbeke D., Rose D.M., Chapman W.C., Pinson W., Wright J.K., Beauchamp R.D., et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J. Nucl. Med. 40:1999;1784-1791
-
(1999)
J. Nucl. Med.
, vol.40
, pp. 1784-1791
-
-
Delbeke, D.1
Rose, D.M.2
Chapman, W.C.3
Pinson, W.4
Wright, J.K.5
Beauchamp, R.D.6
|